Finance

Beta
Lists
VERA:NASDAQ
Vera Therapeutics, Inc
$37.17
+0.49%
(+0.18) 1D
$37.17
0.00% (0.00)
After hours
Closed: Jul 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
$36.73
High
$37.52
Low
$36.12
Mkt. cap
2.67B
Avg. vol.
2.15M
Volume
1.51M
52-wk high
$56.04
52-wk low
$19.07
EPS
-$5.54
Beta
0.92
Shares outstanding
71.78M
No. of employees
339
Open
$36.73
High
$37.52
Low
$36.12
Mkt. cap
2.67B
Avg. vol.
2.15M
Volume
1.51M
52-wk high
$56.04
52-wk low
$19.07
EPS
-$5.54
Beta
0.92
Shares outstanding
71.78M
No. of employees
339
News stories
From sources across the web
About Vera Therapeutics, Inc
CEO-
Employees339
Founded2016
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websiteveratx.com
Analyst ratings
Based on 14 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
13
Hold
1
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current $37.17
$125.00 (+236.29%)
Average
$82.08 (+120.82%)
Lowest
$43.00 (+15.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Laura Chico
Wedbush
Hold
Maintained
$43.00
+15.7%
07/13/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$90.00
+142.1%
07/11/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$91.00
+144.8%
07/09/2026
Unknown Analyst
Jefferies
Buy
Maintained
$60.00
+61.4%
07/08/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
$100.00
+169%
07/07/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$76.00
+104.5%
07/08/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
$125.00
+236.3%
07/08/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
$70.00
+88.3%
07/07/2026
Ritu Baral
TD Cowen
Buy
Maintained
$78.00
+109.8%
07/07/2026
Dina Ramadane
Bank of America Securities
Buy
Reiterated
$70.00
+88.3%
07/07/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
06/24/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$70.00
+88.3%
06/11/2026
Paul Choi
Goldman Sachs
Buy
Maintained
$90.00
+142.1%
06/05/2026
Andy Chen
Wolfe Research
Buy
Maintained
$88.00
+136.8%
06/02/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$86.00
+131.4%
05/22/2026
Unknown Analyst
Wedbush
Hold
Maintained
$35.00
-5.8%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
58.20M
56.47M
59.31M
86.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.95M
27.46M
34.90M
39.12M
Operating expense
80.14M
83.93M
94.21M
125.13M
Total operating expenses
80.14M
83.93M
94.21M
125.13M
Operating income
-80.14M
-83.93M
-94.21M
-125.13M
Other non operating income
-836.00K
-137.00K
-303.00K
-32.00K
EBT including unusual items
-76.53M
-80.29M
-91.10M
-121.03M
EBT excluding unusual items
-76.53M
-80.29M
-90.90M
-120.63M
Income tax expense
-
-
1.00K
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-76.53M
-80.29M
-91.10M
-121.03M
Net profit margin
-
-
-
-
Earnings per share
-1.20
-1.26
-1.39
-1.69
Interest and investment income
6.32M
5.74M
5.52M
6.36M
Interest expense
-1.87M
-1.96M
-1.90M
-1.82M
Net interest expenses
4.45M
3.78M
3.61M
4.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
-80.02M
-83.80M
-94.07M
-124.99M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer